טוען...
In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins
Prolonged remissions were induced in mice bearing advanced BCL1 tumors by the combined approach of nonspecific cytoreductive therapy and administration of a tumor-reactive immunotoxin. Thus, the vast majority of the tumor cells (approximately 95%) were first killed by nonspecific cytoreductive thera...
שמור ב:
| פורמט: | Artigo |
|---|---|
| שפה: | Inglês |
| יצא לאור: |
The Rockefeller University Press
1982
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2186702/ https://ncbi.nlm.nih.gov/pubmed/6804591 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|